Up to 22% of adult de novo AML cases (130, 131) and 10% of MDS (107, 132) harbor somatic mutations in DNMT3A, most occurring at arginine 882 (R882) in the DNMT3A methyltransferase domain. The gene discussed is DNMT3A; the disease is myelodysplastic syndrome.